Physician profile
Daniel J Friedman
NPI 1316267883
$195,566.05
in general payments reported to CMS, 2019-2025
14 companies · $76K in 2025
The $76K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,451 · 2021: $3,849 · 2022: $7,679 · 2023: $36K · 2024: $62K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $80K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Travel and Lodging: $24K · Food and Beverage: $8,583 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,225 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,674.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $56,577.25 |
| Travel and Lodging | $24,238.38 |
| Food and Beverage | $8,583.30 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,225.00 |
| Education | $288.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $90,354.50 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Flexability, Gallant |
| Boston Scientific Corporation | $63,929.32 | 2019-2025 | Ingevity+, General - Therapies, Ingevity Mri |
| Medtronic, INC. | $26,213.55 | 2022-2025 | Selectsecure, Pulseselect, Cobalt Dr Mri Surescan |
| Microport Crm USA INC | $7,423.65 | 2022-2023 | Crm Product |
| Sanofi-Aventis U.S. LLC | $3,408.00 | 2021 | |
| Medtronic Vascular, INC. | $2,606.62 | 2019 | |
| Atricure, INC. | $1,024.00 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $213.58 | 2022-2025 | Optimizer |
| Kestra Medical Technology Services, INC. | $143.31 | 2025 | Assure Wcd |
| Biosense Webster, INC. | $112.58 | 2019-2023 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $107.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.82 | 2023 | Xarelto |
| Ethicon US, LLC | $14.12 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.